Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Freddy E Escorcia

Showing results (1-10 of 76) with videos related to

Pageof 8
Sort By:
Genes & Development|September 17, 2003
Coupled degradation of a small regulatory RNA and its mRNA targets in Escherichia coliEric Massé, Freddy E Escorcia, Susan Gottesman
Cancer Journal (Sudbury, Mass.)|March 25, 2020
Radiomics, Radiogenomics, and Next-Generation Molecular Imaging to Augment Diagnosis of Hepatocellular CarcinomaMeghan Bell, Evrim B Turkbey, Freddy E Escorcia
Theranostics|May 17, 2021
Perspectives on metals-based radioimmunotherapy (RIT): moving forwardJordan M White, Freddy E Escorcia, Nerissa T Viola
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 2025
Size matters: Superior Efficacy of Alpha Particle Radioimmunotherapy in Micrometastases versus MacrometastasesRavi B Patel, Stephen S Adler, Freddy E Escorcia
Cancer Journal (Sudbury, Mass.)|January 24, 2017
Radiotherapy and Immune Checkpoint Blockade for Melanoma: A Promising Combinatorial Strategy in Need of Further InvestigationFreddy E Escorcia, Michael A Postow, Christopher A Barker
European Journal of Nuclear Medicine and Molecular Imaging|June 27, 2021
Why bother with alpha particles?A Paden King, Frank I Lin, Freddy E Escorcia
Npj Imaging|October 29, 2025
Through every lens: assessing the impact of chemical modifications on antibody-conjugates using in vivo imagingVeera V Shivaji R Edupuganti, Freddy E Escorcia, Martin J Schnermann
Cancer Journal (Sudbury, Mass.)|May 16, 2024
Radiopharmaceuticals for Cancer Diagnosis and Therapy: New Targets, New Therapies-Alpha-Emitters, Novel TargetsNeil K Taunk, Freddy E Escorcia, Jason S Lewis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 14, 2025
Challenges Remaining for Yttrium-90 Radioembolization: The Case for Standardized Dosimetry and Comparative Local Control Analyses in Liver TumorsChristopher H Crane, Theodore S Hong, Freddy E Escorcia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 30, 2026
Reply to: Yttrium-90 Radioembolization Provides Durable Local Control and Definitive Radiation TherapyChristopher H Crane, Theodore S Hong, Freddy E Escorcia, et al.
Pageof 8

Showing results (1-10 of 76) with videos related to

Sort By:
Pageof 8
Genes & Development|September 17, 2003
Coupled degradation of a small regulatory RNA and its mRNA targets in Escherichia coliEric Massé, Freddy E Escorcia, Susan Gottesman
Cancer Journal (Sudbury, Mass.)|March 25, 2020
Radiomics, Radiogenomics, and Next-Generation Molecular Imaging to Augment Diagnosis of Hepatocellular CarcinomaMeghan Bell, Evrim B Turkbey, Freddy E Escorcia
Theranostics|May 17, 2021
Perspectives on metals-based radioimmunotherapy (RIT): moving forwardJordan M White, Freddy E Escorcia, Nerissa T Viola
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 2025
Size matters: Superior Efficacy of Alpha Particle Radioimmunotherapy in Micrometastases versus MacrometastasesRavi B Patel, Stephen S Adler, Freddy E Escorcia
Cancer Journal (Sudbury, Mass.)|January 24, 2017
Radiotherapy and Immune Checkpoint Blockade for Melanoma: A Promising Combinatorial Strategy in Need of Further InvestigationFreddy E Escorcia, Michael A Postow, Christopher A Barker
European Journal of Nuclear Medicine and Molecular Imaging|June 27, 2021
Why bother with alpha particles?A Paden King, Frank I Lin, Freddy E Escorcia
Npj Imaging|October 29, 2025
Through every lens: assessing the impact of chemical modifications on antibody-conjugates using in vivo imagingVeera V Shivaji R Edupuganti, Freddy E Escorcia, Martin J Schnermann
Cancer Journal (Sudbury, Mass.)|May 16, 2024
Radiopharmaceuticals for Cancer Diagnosis and Therapy: New Targets, New Therapies-Alpha-Emitters, Novel TargetsNeil K Taunk, Freddy E Escorcia, Jason S Lewis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 14, 2025
Challenges Remaining for Yttrium-90 Radioembolization: The Case for Standardized Dosimetry and Comparative Local Control Analyses in Liver TumorsChristopher H Crane, Theodore S Hong, Freddy E Escorcia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 30, 2026
Reply to: Yttrium-90 Radioembolization Provides Durable Local Control and Definitive Radiation TherapyChristopher H Crane, Theodore S Hong, Freddy E Escorcia, et al.
Pageof 8